BREAST ATYPICAL LOBULAR HYPERPLASIA
Clinical trials for BREAST ATYPICAL LOBULAR HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new BREAST ATYPICAL LOBULAR HYPERPLASIA trials appear
Sign up with your email to follow new studies for BREAST ATYPICAL LOBULAR HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tamoxifen gel vs. pill: can a cream lower breast cancer risk?
Disease control TerminatedThis study tested whether a tamoxifen skin gel works as well as the standard tamoxifen pill to lower breast cancer risk in women with atypical hyperplasia or lobular carcinoma in situ (LCIS). About 65 women were enrolled, but the study was stopped early. The goal was to see short…
Matched conditions: BREAST ATYPICAL LOBULAR HYPERPLASIA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Genetic risk tool tested for breast cancer in minority women
Knowledge-focused TerminatedThis study looked at whether adding a genetic risk score to standard breast cancer risk assessments helps African American and Hispanic women decide about extra screening or prevention. The study enrolled 19 women at higher risk for breast cancer. The goal was to see if personali…
Matched conditions: BREAST ATYPICAL LOBULAR HYPERPLASIA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC